Skip to main content
Clinical Trials/NL-OMON42994
NL-OMON42994
Withdrawn
Not Applicable

Study to Determine Presence of Prediabetes in Subjects with Cardiovascular Disease - Prescreening Pilot

Janssen-Cilag0 sites70 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
diabetes
Sponsor
Janssen-Cilag
Enrollment
70
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Man or woman of \*18 years of age
  • \* Documented symptomatic atherosclerotic CV disease including a history of one of the following:
  • \* Myocardial infarction
  • \* Hospitalized admission for unstable angina
  • \* Percutaneous coronary intervention (with or without stenting)
  • \* Peripheral revascularization (angioplasty or surgery)
  • JNJ\-28431754
  • Clinical Protocol 28431754PRD0001
  • Approved, Date: 29 March 2016
  • \* Symptomatic with documented hemodynamically significant carotid or peripheral vascular

Exclusion Criteria

  • \* History of T2DM, type 1 diabetes mellitus, latent autoimmune diabetes in adults (LADA), diabetic
  • ketoacidosis
  • \* History of hereditary glucose\-galactose malabsorption or primary renal glycosuria
  • \* History of use of a glucose lowering drug (other than short\-term use during a hospitalization or for
  • gestational diabetes; or subjects with a history of gestational diabetes may be included if at least
  • 3 months has passed since the discontinuation of a glucose lowering drug)

Outcomes

Primary Outcomes

Not specified

Similar Trials